Ascending aortic blood pressure waveform is related to coronary atherosclerosis in hypertensive as well as in normotensive subjects

Blood Pressure

Volumn 16, Issue 4, 2007, Pages 246-253

  Jankowski, Piotr ^a   Kawecka Jaszcz, Kalina ^a   Czarnecka, Danuta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Atherosclerosis; Blood pressure; Coronary artery disease; Hypertension; Pulsatility

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA PRESSURE; ARTICLE; ASCENDING AORTA; BLOOD PRESSURE MEASUREMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

ADULT; AGED; AORTA; BLOOD PRESSURE; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PULSATILE FLOW;

EID: 35148818016     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050701428125     Document Type: Article

References (31)

1. Safar, M. E., Blacher, J., Pannier, B., Guerin, A. P., Marchais, S. J. and Guyonvarc'h, P. M. (2002) Central pulse pressure and mortality in end-stage renal disease. Hypertension, 39, pp. 735-738.
2. Safar, M. E., Levy, B. I. and Struijker-Boudier, H. (2003) Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation, 107, pp. 2864-2869.
3. Dart, A. M. and Kingwell, B. A. (2001) Pulse pressure - A review of mechanisms and clinical relevance. J Am Coll Cardiol, 37, pp. 975-984.
4. Jankowski, P., Bilo, G. and Kawecka-Jaszcz, K. (2007) The pulsatile component of blood pressure - Its role in the pathogenesis of atherosclerosis. Blood Press
5. Xu, Q. (2000) Biomechanical-stress-induced signaling and gene expression in the development of atherosclerosis. Trends Cardiovasc Med, 10, pp. 35-41.
6. Yamamoto, K., Ikeda, U. and Shimada, K. (2003) Role of mechanical stress in monocytes/macrophages: Implications for atherosclerosis. Curr Vasc Pharmacol, 1, pp. 315-319.
7. Jankowski, P., Kawecka-Jaszcz, K., Czarnecka, D., Brzozowska-Kiszka, M., Styczkiewicz, K. and Styczkiewicz, M. (2004) Ascending aortic, but not brachial blood pressure-derived indices are related to coronary atherosclerosis. Atherosclerosis, 176, pp. 151-155.
8. Guray, Y., Guray, U., Altay, H., Cay, S., Yilmaz, M. B. and Kisacik, H. L. (2005) Pulsatility of ascending aortic blood pressure waveform is associated with increased risk of coronary heart disease. Blood Press, 14, pp. 293-297.
9. Nakayama, Y., Hayashi, T., Yoshimaru, K., Tsumura, K. and Ueda, H. (2002) Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease. J Hum Hypertens, 16, pp. 837-841.
10. Philippe, F., Chemaly, E., Blacher, J., Mourad, J. J., Dibie, A. and Larrazet, F. (2002) Aortic pulse pressure and extent of coronary artery disease in percutaneous transluminal coronary angioplasty candidates. Am J Hypertens, 15, pp. 672-677.
11. Danchin, N., Benetos, A., Lopez-Sublet, M., Demicheli, T., Safar, M., Mourad, J. J. and on behalf of the ESCAPP Investigators (2004) Aortic pulse pressure is related to the presence and extent of coronary artery disease in men undergoing diagnostic coronary angiography: A multicenter study. Am J Hypertens, 17, pp. 129-133.
12. Chirinos, J. A., Zambrano, J. P., Chakko, S., Veerani, A., Schob, A. and Perez, G. (2005) Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease. Am J Cardiol, 96, pp. 645-658.
13. Jankowski, P., Kawecka-Jaszcz, K., Czarnecka, D., Brzozowska-Kiszka, M., Styczkiewicz, K. and Curyło, A. M. (2006) Ascending aortic pulsatility and pulsatility index are better predictors of event-free survival compared to systolic, diastolic, mean and pulse pressure. The results from the ABPS Study. Eur Heart J, 27, p. 114 [abstract].
14. Williams, B., Lacy, P. S., Thom, S. M., Cruickshank, K., Stanton, A. and Collier, D. (2006) Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation, 113, pp. 1213-1225.
15. Jankowski, P., Kawecka-Jaszcz, K., Czarnecka, D., Brzozowska-Kiszka, M., Posnik-Urbanska, A. and Styczkiewicz, K. (2006) Ascending aortic blood pressure-derived indices are not correlated with the extent of coronary artery disease in patients with impaired left ventricular function. Atherosclerosis, 184, pp. 370-376.
16. Austen, W. G., Edwards, J. E., Frye, R. L., Gensini, G. G., Gott, V. L. and Griffith, L. S. (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation, 51, pp. 5-40.
17. Zebrack, J. S., Muhlestein, J. B., Horne, B. D. and Anderson, J. L. (2002) C-reactive protein and angiographic coronary artery disease: Independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol, 39, pp. 632-637.
18. Gensini, G. G. (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 51, p. 606.
19. Kaneda, H., Taguchi, J., Ogasawara, K., Aizawa, T. and Ohno, M. (2002) Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis, 62, pp. 221-225.
20. Al-Fakhri, N., Linhart, R. E., Philipp, M., Heidt, M., Hehrlein, F. W. and Gardemann, A. (2003) Endotelin-1 and vasopressin plasma levels are not associated with the insertion/deletion polymorphism of the human angiotensin I-converting enzyme gene in patients with coronary artery disease. J Hum Hypertens, 17, pp. 133-138.
21. O'Rourke, M. F. and Adji, A. (2005) An updated clinical primer on large artery mechanics: Implications of pulse waveform analysis and arterial tonometry. Curr Opin Cardiol, 20, pp. 275-281.
22. Bakris, G. L., Bank, A. J., Kass, D. A., Neutel, J. M., Preston, R. A. and Oparil, S. (2004) Advanced glycation end-product cross-link breakers: A novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens, 17, pp. 23S-30S.
23. Kass, D. A. (2005) Ventricular arterial stiffening. Integrating the pathophysiology. Hypertension, 46, pp. 185-193.
24. Vaccarino, V., Holford, T. R. and Krumholz, H. M. (2000) Pulse pressure and the risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol, 36, pp. 130-138.
25. Benetos, A., Rudnichi, A., Safar, M. and Guize, L. (1998) Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension, 32, pp. 560-564.
26. Kiefer, C. R., McKenney, J. B., Trainor, J. F. and Snyder, L. M. (2005) Pulse pressure-driven neutral lipid accumulation and correlative proinflammatory markers of accelerated atherogenesis. Atherosclerosis, 183, pp. 17-24.
27. Pauca, A. L., O'Rourke, M. F. and Kon, N. D. (2001) Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension, 38, pp. 932-937.
28. Weber, T., Auer, J., O'Rourke, M. F., Kvas, E., Lassnig, E. and Berent, R. (2004) Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation, 109, pp. 184-189.
29. Kelly, R. P., Millasseau, S. C., Ritter, J. M. and Chowienczyk, P. J. (2001) Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension, 37, pp. 1429-1433.
30. Morgan, T., Lauri, J., Bertram, D. and Anderson, A. (2004) Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens, 17, pp. 118-123.
31. Safar, M. E. and O'Rourke, M. F. (2005) Pulse pressure and antihypertensive agents. Hypertension, 46, p. e6.